-
Systemic Inflammatory Response Syndrome Treatment Market Size Worth USD 24.76 Billion by 2034 Fueled by Growing ICU Admissions
23 Sep 2025 13:47 GMT
… and Immunomodulatory Drugs
Development of targeted … Treatment Market Opportunity Development of Novel Drug … , and anti-inflammatory medications, that severe inflammatory … health solutions ➡️ Inflammatory Bowel Disease Treatment Market: Track innovation …
-
Pioneering initiative launched to connect data from IBD registries around the world
23 Sep 2025 14:06 GMT
… to securely connect data from inflammatory bowel disease (IBD) registries around the world.
GLIDE … development of better treatments for people living with IBD.
Founding GLIDE members …
-
With new FDA nod in ulcerative colitis, J&J's Tremfya becomes 1st IL-23 med with IV and subQ options across IBD treatment
23 Sep 2025 02:33 GMT
… Tremfya’s presence in inflammatory bowel disease (IBD) and, in doing so … the process for patients seeking treatment.
"Historically, IL … opportunity after AbbVie’s drug topped its Tremfya predecessor … one of two immunology drugs alongside Rinvoq that AbbVie …
-
IBD 50's Tempus AI Pulls Back From Record High After Another FDA Clearance
23 Sep 2025 02:40 GMT
… Monday after the Food and Drug Administration cleared its new device … even more critical for personalized treatments for patients with cancer.… AI stock has a strong IBD Digital Relative Strength Rating of … X/Twitter at @AGatlin_IBD.
YOU MAY ALSO LIKE:
…
-
Crohn’s & Colitis Foundation and international partners launch GLIDE: An integrated global registry to advance IBD care
22 Sep 2025 14:53 GMT
… to securely connect data from inflammatory bowel disease (IBD) registries around the world.
… development of better treatments for people living with IBD.
Founding GLIDE … research and patient support for inflammatory bowel disease (IBD), with the mission of …
-
MBX Biosciences Catapults 125%, Hitting A Nine-Month High, On Thyroid Drug Promise
22 Sep 2025 14:47 GMT
… for its experimental thyroid disease treatment.
The biotech company is testing … all patients knowingly receive the drug — 79% of patients were … X/Twitter at @AGatlin_IBD.
YOU MAY ALSO LIKE:
CDC … What It Means For Investors.
IBD Stock Of The Day: See …
-
Lifestyle factors that reduce the risk of developing IBD
21 Sep 2025 13:48 GMT
… chance of developing inflammatory bowel disease (IBD).
The study clarifies … IBD, and explores non-traditional treatments like stress management, sleep and hydration.
Inflammatory Bowel Disease (IBD … like nonsteroidal anti-inflammatory drugs (NSAIDs) can …
-
Trethera Receives $1.8 Million NIH Grant to Advance TRE-515 Development for Crohn’s Disease
23 Sep 2025 14:07 GMT
… a Crohn’s disease treatment. Trethera’s lead drug candidate, TRE-515 … ’s market-leading drug, Stelara. TRE-515 blocked inflammatory bowel disease symptoms in mice … pioneering the development of novel treatments for autoimmune diseases and cancers …
-
High Stakes, High Impact: $20 million from the Weston Family Foundation awarded to cutting-edge health research projects at the forefront of innovation
23 Sep 2025 12:00 GMT
… of dementia. Effective personalized treatments for Alzheimer’s disease depend … Alain Stintzi, University of Ottawa Inflammatory bowel disease (IBD) is a lifelong, chronic disease … to incorporate dietary recommendations into treatment plans. This project will …
-
South Africa’s rooibos tea: can it improve digestion?
23 Sep 2025 14:25 GMT
… irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and other chronic health problems … , dexamethasone, a common steroid drug used to reduce inflammation in … supplements, as natural therapies for inflammatory bowel disease, or in everyday foods …
About
© 1995-2025